Dr. Rachel Anna Moses, MD

Dr. Moses practices at White River Junction VA Medical Center - Behavioral Health in White River Junction, Vermont.

Dr. Moses' NPI, 1174816300, was assigned on May 20, 2011. Dr. Moses graduated from University of Kansas School of Med (KC/Wich/Sal) in 2011. Dr. Moses holds New Hampshire license 18989.

Dr. Moses' primary practice is White River Junction VA Medical Center - Behavioral Health, at 215 North Main Street Unit 116-A, White River Junction, VT 05009.

Dr. Moses' primary practice is White River Junction VA Medical Center - Behavioral Health in White River Junction, Vermont. Dr. Moses is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Moses to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moses practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Moses' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Moses is licensed in New Hampshire.

CMS data shows 328 Medicare services from Dr. Moses across 8 procedure codes in 2024, for 213 Medicare patients. Medicare paid $20,546 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 213 Medicare patients who saw Dr. Moses in 2024. The largest group is 65 to 74, with 83 patients. 72% of them have high blood pressure, and 62% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moses' median patient age at 67, with 33% women.

In 2024, Dr. Moses wrote 258 Medicare Part D claims for 90 patients. 68% of them were for generic drugs. CMS names the drug for 176 of them, across 5 drugs with 11 or more claims each, at $41,279 in total drug cost. In 2023, CMS named 157 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Moses for performance year 2024, reported as part of a group. Dr. Moses accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moses as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Dr. Moses, published from 2012 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Kidney, Injury Severity Score and Postoperative Complications. Dr. Moses has published most often in Urology. Dr. Moses' most frequent co-authors are Sorena Keihani, MD, Frank Nelson Burks and Judith Carolin Hagedorn, MD.

CMS Open Payments shows 37 general payments to Dr. Moses from 3 drug and device companies from 2016 to 2025. Grants make up the largest share, 97% of the total. Boston Scientific Corporation paid the most, $51,081.

Dr. Moses graduated from University of Kansas School of Med (KC/Wich/Sal) in 2011.